Patents by Inventor Gary L. Breton

Gary L. Breton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acid sequences relating to for diagnostics and therapeutics
    Patent number: 7090973
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Bacteroides fragilis that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Grant
    Filed: April 4, 2000
    Date of Patent: August 15, 2006
    Assignee: Oscient Pharmaceuticals Corporation
    Inventor: Gary L. Breton
  • Nucleic acid and amino acid sequences relating to M. catarrhalis for diagnostics and therapeutics
    Patent number: 6673910
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Moracella catarrhalis that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Grant
    Filed: April 4, 2000
    Date of Patent: January 6, 2004
    Assignee: Genome Therapeutics Corporation
    Inventor: Gary L. Breton
  • Nucleic acid amino acid sequences relating to Klebsiella pneumoniae for diagnostics and therapeutics
    Patent number: 6610836
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Klebsiella pneumoniae that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Grant
    Filed: January 27, 2000
    Date of Patent: August 26, 2003
    Assignee: Genome Therapeutics Corporation
    Inventors: Gary L. Breton, Mark Osborne
  • Nucleic acid and amino acid sequences relating to Proteus mirabilis for diagnostics and therapeutics
    Patent number: 6605709
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Proteus fragilis that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Grant
    Filed: April 5, 2000
    Date of Patent: August 12, 2003
    Assignee: Genome Therapeutics Corporation
    Inventor: Gary L. Breton